2,142
Views
1
CrossRef citations to date
0
Altmetric
Research Aricles

Analysis of Mexican young women with primary ovarian insufficiency induced by gynaecological and haematological cancer management

, , , , , & ORCID Icon show all

References

  • Angioli R, Luvero D, Armento G, Capriglione S, Plotti F, Scaletta G, et al. 2018. Hormone replacement therapy in cancer survivors. Critical Reviews in Oncology/Hematology 124:51–60. (December 2017):
  • ASCVD n.d. ASCVD risk estimator +. American College of Cardiology. https://tools.acc.org/ascvd-risk-estimator-plus/#!/calculate/estimate/
  • Bradley KA, Petereit DG. 2006. Radiation Therapy for Gynecologic Malignancies. Hematology/Oncology Clinics of North America 20:347–361.
  • Chapman C, Cree L, Shelling AN. 2015. The genetics of premature ovarian failure: Current perspectives. International Journal of Women's Health 7:799–810.
  • Deli T, Orosz M, Jakab A. 2020. Hormone Replacement Therapy in Cancer Survivors – Review of the Literature. Pathology Oncology Research 26:63–78.
  • Donnez J, Jadoul P, Squifflet J, Van Langendonckt A, Donnez O, Van Eyck A-S, et al. 2010. Ovarian tissue cryopreservation and transplantation in cancer patients. Best Practice & Research Clinical Obstetrics & Gynaecology 24:87–100.
  • Edey KA, Rundle S, Hickey M. 2018. Hormone replacement therapy for women previously treated for endometrial cancer. Cochrane Database Systemic Reviews 2018.
  • Faubion SS, Kuhle CL, Shuster LT, Rocca WA. 2015. Long-term health consequences of premature or early menopause and considerations for management. Climacteric: The Journal of the International Menopause Society 18:483–491.
  • Fenton A. 2015. Premature ovarian insufficiency: Pathogenesis and management. Journal of Mid-Life Health 6:147–153.
  • Ghahremani-Nasab M, Ghanbari E, Jahanbani Y, Mehdizadeh A, Yousefi M. 2020. Premature ovarian failure and tissue engineering. Journal of Cellular Physiology 235:4217–4226.
  • Gialeraki A, Valsami S, Pittaras T, Panayiotakopoulos G, Politou M. 2018. Oral Contraceptives and HRT Risk of Thrombosis. Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 24:217–225.
  • Hamoda H, British Menopause Society and Women’s Health Concern 2017. The British Menopause Society and Women’s Health Concern recommendations on the management of women with premature ovarian insufficiency. Post Reproductive Health 23:22–35.
  • Honigberg MC, Zekavat SM, Aragam K, Finneran P, Klarin D, Bhatt DL, et al. 2019. Association of Premature Natural and Surgical Menopause with Incident Cardiovascular Disease. JAMA 322:2411–2421.
  • Ibeanu O, Modesitt SC, Ducie J, Von Gruenigen V, Agueh M, Fader AN. 2011. Hormone replacement therapy in gynecologic cancer survivors: Why not? Gynecologic Oncology 122:447–454.
  • Islami F, Ward EM, Sung H, Cronin KA, Tangka FKL, Sherman RL, et al. 2021. Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics. JNCI: Journal of the National Cancer Institute 113:1648–1669.
  • Isla-Ortiz D, Palomares-Castillo E, Mille-Loera JE, Ramírez-Calderón N, Mohar-Betancourt A, Meneses-García AA, et al. 2020. Cervical Cancer in Young Women: Do They Have a Worse Prognosis? A Retrospective Cohort Analysis in a Population of Mexico. The Oncologist 25:e1363–e1371.
  • Knowlton AA. Lee AR 2017. Estrogen and the Cardiovascular System HHS Public Access. Physiol Behav 176:139–148.
  • Langrish JP, Mills NL, Bath LE, Warner P, Webb DJ, Kelnar CJ, et al. 2009. Cardiovascular effects of physiological and standard sex steroid replacement regimens in premature ovarian failure. Hypertension 53:805–811.
  • Lee SR, Cho MK, Cho YJ, Chun S, Hong SH, Hwang KR, Academic Committee of the Korean Society of Menopause, et al. 2020. The 2020 Menopausal Hormone Therapy Guidelines. Journal of Menopausal Medicine 26:69–98.
  • Li XT, Li PY, Liu Y, Yang HS, He LY, Fang YG, et al. 2020. Health-related quality-of-life among patients with premature ovarian insufficiency: a systematic review and meta-analysis. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation 29:19–36.
  • Luisi S, Orlandini C, Regini C, Pizzo A, Vellucci F, Petraglia F. 2015. Premature ovarian insufficiency: From pathogenesis to clinical management. Journal of Endocrinological Investigation 38:597–603.
  • Meirow D. 2000. Reproduction post-chemotherapy in young cancer patients. Molecular and Cellular Endocrinology 169:123–131.
  • Murphy E. 2011. Estrogen signaling and cardiovascular disease. Circulation Research 109:687–696.
  • NICE 2015. Menopause: Diagnosis and Management (NG23). https://www.nice.org.uk/guidance/ng23/resources/menopause-diagnosis-andmanagement-1837330217413
  • O'Donnell RL, Clement KM, Edmondson RJ. 2016. Hormone replacement therapy after treatment for a gynaecological malignancy. Current Opinion in Obstetrics & Gynecology 28:32–41.
  • Reslan OM, Khalil RA. 2012. Vascular effects of estrogenic menopausal hormone therapy. Reviews on Recent Clinical Trials 7:47–70.
  • Van Dijk GM, Kavousi M, Troup J, Franco OH. 2015. Health issues for menopausal women: The top 11 conditions have common solutions. Maturitas 80:24–30.
  • Vermeulen RFM, Beurden M. v, Korse CM, Kenter GG. 2017. Impact of risk-reducing salpingo-oophorectomy in premenopausal women. Climacteric: The Journal of the International Menopause Society 20:212–221. 10.1080/13697137.2017.1285879
  • Wallace WHB, Thomson AB, Kelsey TW. 2003. The radiosensitivity of the human oocyte. Human Reproduction 18:117–121.